These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10433467)

  • 21. Reply to "Early subcutaneous wash-out in acute extravasations", by R. Giunta (Ann Oncol 2004; 15: 1146), and to the reply by D. Schrijvers (Ann Oncol 2004; 15: 1147).
    Chacon MR
    Ann Oncol; 2005 Jan; 16(1):170. PubMed ID: 15678595
    [No Abstract]   [Full Text] [Related]  

  • 22. Totect: a new agent for treating anthracycline extravasation.
    Schulmeister L
    Clin J Oncol Nurs; 2007 Jun; 11(3):387-95. PubMed ID: 17623623
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Different anthracycline derivates for reducing cardiotoxicity in cancer patients.
    van Dalen EC; Michiels EM; Caron HN; Kremer LC
    Cochrane Database Syst Rev; 2006 Oct; (4):CD005006. PubMed ID: 17054231
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemotherapy during pregnancy: what is really safe?
    Peccatori F; Martinelli G; Gentilini O; Goldhirsch A
    Lancet Oncol; 2004 Jul; 5(7):398. PubMed ID: 15231245
    [No Abstract]   [Full Text] [Related]  

  • 25. An increase of serum lipids after cumulative doses of doxorubicin and epirubicin in experimental animals.
    Stathopoulos GP; Papadopoulos NG; Stephanopoulou A; Dontas I; Kotsarelis D; Karayannacos PE
    Anticancer Res; 1996; 16(6B):3429-33. PubMed ID: 9042202
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination of transcatheter arterial embolization and percutaneous ethanol injection for hepatocellular carcinoma: comparison of efficacies of doxorubicin and epirubicin in transcatheter arterial embolization.
    Nakamura S; Tanaka K
    Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-46-S6-49. PubMed ID: 9151916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical results after doxorubicin extravasation treated with excision guided by fluorescence microscopy.
    Andersson AP; Dahlstrøm KK
    Eur J Cancer; 1993; 29A(12):1712-4. PubMed ID: 8398299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravesical epirubicin versus doxorubicin for superficial bladder tumors (stages pTa and pT1): a randomized prospective study.
    Ali-el-Dein B; el-Baz M; Aly AN; Shamaa S; Ashamallah A
    J Urol; 1997 Jul; 158(1):68-73; discussion 73-4. PubMed ID: 9186325
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epirubicin: is it like doxorubicin in breast cancer? A clinical review.
    Khasraw M; Bell R; Dang C
    Breast; 2012 Apr; 21(2):142-9. PubMed ID: 22260846
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiotoxicity of epirubicin versus doxorubicin: cost and clinical results.
    Ventura GJ
    J Clin Oncol; 2005 Apr; 23(12):2873; author reply 2873-4. PubMed ID: 15838014
    [No Abstract]   [Full Text] [Related]  

  • 31. Contradistinction between doxorubicin and epirubicin: in-vitro interaction with blood components.
    Ramanathan-Girish S; Boroujerdi M
    J Pharm Pharmacol; 2001 Jun; 53(6):815-21. PubMed ID: 11428657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Doxorubicin vs epirubicin, report of a second-line randomized phase II/III study in advanced breast cancer. EORTC Breast Cancer Cooperative Group.
    Bontenbal M; Andersson M; Wildiers J; Cocconi G; Jassem J; Paridaens R; Rotmensz N; Sylvester R; Mouridsen HT; Klijn JG; van Oosterom AT
    Br J Cancer; 1998 Jun; 77(12):2257-63. PubMed ID: 9649142
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Successful dexrazoxane treatment of a potentially severe extravasation of concentrated doxorubicin.
    Conde-Estévez D; Saumell S; Salar A; Mateu-de Antonio J
    Anticancer Drugs; 2010 Sep; 21(8):790-4. PubMed ID: 20671512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of epirubicin and doxorubicin cardiotoxicity induced by low doses: evolution of the diastolic and systolic parameters studied by radionuclide angiography.
    Cottin Y; Touzery C; Dalloz F; Coudert B; Toubeau M; Riedinger A; Louis P; Wolf JE; Brunotte F
    Clin Cardiol; 1998 Sep; 21(9):665-70. PubMed ID: 9755384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful experience utilizing dexrazoxane treatment for an anthracycline extravasation.
    Tyson AM; Gay WE
    Ann Pharmacother; 2010 May; 44(5):922-5. PubMed ID: 20371757
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum troponin T levels in adults undergoing anthracycline therapy.
    Raderer M; Kornek G; Weinländer G; Kastner J
    J Natl Cancer Inst; 1997 Jan; 89(2):171. PubMed ID: 8998187
    [No Abstract]   [Full Text] [Related]  

  • 37. Prevention of adriamycin-induced full-thickness skin loss using hyaluronidase infiltration.
    Disa JJ; Chang RR; Mucci SJ; Goldberg NH
    Plast Reconstr Surg; 1998 Feb; 101(2):370-4. PubMed ID: 9462769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The influence of elevated liver function parameters on the pharmacokinetics of doxorubicin and epirubicin--a population based pharmacokinetic study of CESAR-APOH. Central European Society for Anticancer Drug Research. Working Group for Pharmacology in Oncology and Hematology.
    Müller HJ; Grubert M; Hilger R; Richly H; Port R; Scheulen M; Mross K;
    Int J Clin Pharmacol Ther; 2002 Dec; 40(12):575-7. PubMed ID: 12503820
    [No Abstract]   [Full Text] [Related]  

  • 39. Reader seeks clarification on the role of glucocorticoids and sodium bicarbonate.
    Keenan AM
    Oncol Nurs Forum; 1998 May; 25(4):653-4. PubMed ID: 9599341
    [No Abstract]   [Full Text] [Related]  

  • 40. [Emergency open surgical treatment of extravasations of cytostatic agents in the upper extremity].
    Telisselis P; Heers G; Plock B; Baier C; Neugebauer R; Füchtmeier B
    Handchir Mikrochir Plast Chir; 2010 Aug; 42(4):247-50. PubMed ID: 19890780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.